Conatus Pharmaceuticals (CNAT) null Earnings

12MarConfirmed
May 19
Aug 19
Nov 19
Mar 20
-0.14
-0.1
-0.06
-0.02

Details

Expected EPS
N/A
Actual EPS
-0.0823
Surprise EPS
-0.08
Surprise Percent
+∞%

Description

Conatus Pharmaceuticals (CNAT) has reported earnings of -0.0823 per share for .

0 Comments

Share your thoughts